Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Frontiers | CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients | Molecular Medicine | Full Text
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain | SpringerLink
Pancreas: Pancreatic Adenocarcinoma Imaging Pearls - Educational Tools | CT Scanning | CT Imaging | CT Scan Protocols - CTisus
Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria | Radiology
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer | World Journal of Surgical Oncology | Full Text
Resectable and Borderline Resectable Pancreatic Cancer | SpringerLink
Moving the Bar in Pancreatic Cancer
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria | Radiology
Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis | Scientific Reports
Treatment for potentially resectable exocrine pancreatic cancer - UpToDate
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma - eBioMedicine
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes | npj Precision Oncology
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Advances in the Treatment of Pancreatic Cancer | IntechOpen
New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer
Pancreatic Cancer—the Current Landscape - touchONCOLOGY
Definition and Management of Borderline Resectable Pancreatic Cancer
